The frequency of mutations in the factor VIII ... Acquired hemophilia puts pregnant women, cancer patients, and those with multiple sclerosis at the most risk. A family's medical background ...

Factor therapy is an even bigger burden, requiring once- or twice-weekly infusions. How does gene therapy work? The currently licensed gene therapies for hemophilia A and B deliver genes via adeno ...

A recent study led by MedUni Vienna provides new insights into the mechanisms of coagulation in persons with hemophilia A ... of certain coagulation factors, which can lead to life-threatening ...

In the Phase III HAVEN 4 study, the ABR for people aged 12 years or older with hemophilia A with or without factor VIII ...

Hemophilia is a hereditary blood disorder characterized by a deficiency of certain coagulation factors, which can lead to life-threatening bleeding if left untreated. Why hemophilia A (with factor ...

Interim findings showed, the estimated mean annualized bleeding rate for treated bleeds was 0.53, with a median ABR of 0. Topline results were announced from a phase 3 trial evaluating Mim8 in ...

Multiple hospitalizations and long-term Crohn disease duration are major risk factors for gallstone disease. A pooled gallstone prevalence of 14.9% was found in Crohn disease patients, with high ...

Results of two large studies highlight a link between anemia and risk for postpartum hemorrhage and maternal death, with ...